Jpmorgan Chase & Co »

Atara Biotherapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 2.2M 0.51
2023-09-30 $13M 8.7M 1.48
2023-06-30 $12M 7.7M 1.61
2023-03-31 $32M 7.6M 4.27
2022-12-31 $25M 7.5M 3.28
2022-06-30 $69M 8.9M 7.79
2022-03-31 $76M 8.2M 9.29
2021-12-31 $117M 7.4M 15.76
2021-03-31 $99M 6.7M 14.78
2020-12-31 $122M 6.2M 19.63
2020-09-30 $73M 5.6M 13.08
2020-06-30 $61M 4.2M 14.57
2020-03-31 $24M 2.9M 8.51
2019-12-31 $44M 2.7M 16.33
2019-09-30 $36M 2.6M 14.12
2019-06-30 $38M 1.9M 20.24
2019-03-31 $76M 1.9M 39.75
2018-12-31 $43M 1.2M 34.74
2018-09-30 $50M 1.2M 41.35
2018-06-30 $33M 887k 36.75
2018-03-31 $258k 6.6k 38.94
2017-12-31 $104k 5.8k 18.03
2016-06-30 $2.0M 90k 22.51
2016-03-31 $1.2M 63k 19.03
2015-12-31 $1.6M 61k 26.00
2015-09-30 $5.5M 176k 31.00
2015-06-30 $11M 201k 52.80
2015-03-31 $6.0M 144k 41.55
2014-12-31 $4.0M 150k 26.75